Axon officer proposes $487K Rule 144 stock sale

Axon Enterprise, Inc. officer Isaiah Fields filed a notice of proposed sale of 1,017 shares of common stock under Rule 144.

Rhea-AI Filing Summary

Axon Enterprise, Inc. officer Isaiah Fields filed a notice of proposed sale of 1,017 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $486,990.45, based on Axon’s reported 81,237,415 shares outstanding and a proposed sale date of September 11, 2026 on NASDAQ.

Key Figures

Shares proposed to be sold: 1,017 shares Aggregate market value of proposed sale: $486,990.45 Shares outstanding: 81,237,415 shares +2 more

5 metrics

Shares proposed to be sold 1,017 shares Common stock under Rule 144 for account of officer Isaiah Fields

Aggregate market value of proposed sale $486,990.45 Value of 1,017 Axon common shares covered by the notice

Shares outstanding 81,237,415 shares Axon Enterprise, Inc. common stock outstanding as referenced in the notice

Proposed sale date September 11, 2026 Planned date of sale on NASDAQ

Acquisition date of related RSUs August 31, 2026 Date tied to Restricted Stock Units from issuer

Key Terms

Rule 144, Restricted Stock Units, aggregate market value, NASDQ

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 08/31/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 1017 | 486990.45"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

NASDQ market

"81237415 | 09/11/2026 | NASDAQ"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose about AXON?

The filing states that an Axon Enterprise, Inc. officer, Isaiah Fields, has notified of a proposed sale of 1,017 shares of Axon common stock under Rule 144, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.

How many AXON shares are proposed to be sold and at what value?

The notice covers a proposed sale of 1,017 shares of Axon Enterprise, Inc. common stock, with an aggregate market value of $486,990.45 as reported in the filing.

Who is the insider involved in this AXON Form 144 filing?

The person for whose account the securities are to be sold is Isaiah Fields, identified in the filing as an officer of Axon Enterprise, Inc.

When is the proposed sale of AXON shares expected to occur?

The filing lists a proposed sale date of September 11, 2026 for the 1,017 shares of Axon Enterprise, Inc. common stock to be sold on NASDAQ.

What type of AXON securities are covered and how were they acquired?

The securities are common stock, related to Restricted Stock Units with an acquisition date of August 31, 2026, and the acquisition is described as being from the issuer.

How many AXON shares were outstanding as referenced in this filing?

The Form 144 notice references 81,237,415 shares of Axon Enterprise, Inc. common stock as outstanding, providing context for the proposed Rule 144 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:32 PM EDT Accepted by SEC EDGAR 09/11/2026 - 04:32 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002104464
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Axon Enterprise, Inc.
SEC File Number	001-16391
Address of Issuer	17800 North 85th Street Scottsdale ARIZONA 85255
Phone	(1-800)-978-2737
Name of Person for Whose Account the Securities are To Be Sold	ISAIAH FIELDS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1017	486990.45	81237415	09/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2026	Restricted Stock Units	Issuer			1017	08/31/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Isaiah Fields
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)